Research advances in renal replacement therapy for hepatorenal syndrome
Hepatorenal syndrome (HRS) is a serious complication of the end-stage liver disease. The overall treatment outcome of HRS is not satisfactory, with a short survival time and a poor prognosis. Currently, renal replacement therapy is one of the main non-transplantation therapeutic methods, but its cli...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2016-03-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=7280 |
id |
doaj-ca858a54927c41b6955eeaadf36400d7 |
---|---|
record_format |
Article |
spelling |
doaj-ca858a54927c41b6955eeaadf36400d72020-11-24T22:29:16ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562016-03-0132360560810.3969/j.issn.1001-5256.2016.03.046Research advances in renal replacement therapy for hepatorenal syndromeCHEN Li0MEI Yong1YANG Yibin2Department of Nephropathy, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, ChinaDepartment of Nephropathy, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, ChinaDepartment of Nephropathy, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, ChinaHepatorenal syndrome (HRS) is a serious complication of the end-stage liver disease. The overall treatment outcome of HRS is not satisfactory, with a short survival time and a poor prognosis. Currently, renal replacement therapy is one of the main non-transplantation therapeutic methods, but its clinical effect remains controversial. This review summarizes the research on HRS and advances in the clinical effect of renal replacement therapy for HRS, and points out that renal replacement therapy is not suitable as the conventional therapy for HRS, but it can be applied as the pre-transplantation transitional treatment for patients with a plan for liver transplantation, as well as the short-term treatment for non-transplantation patients who do not respond to vasoconstrictors.http://www.lcgdbzz.org/qk_content.asp?id=7280 |
collection |
DOAJ |
language |
zho |
format |
Article |
sources |
DOAJ |
author |
CHEN Li MEI Yong YANG Yibin |
spellingShingle |
CHEN Li MEI Yong YANG Yibin Research advances in renal replacement therapy for hepatorenal syndrome Linchuang Gandanbing Zazhi |
author_facet |
CHEN Li MEI Yong YANG Yibin |
author_sort |
CHEN Li |
title |
Research advances in renal replacement therapy for hepatorenal syndrome |
title_short |
Research advances in renal replacement therapy for hepatorenal syndrome |
title_full |
Research advances in renal replacement therapy for hepatorenal syndrome |
title_fullStr |
Research advances in renal replacement therapy for hepatorenal syndrome |
title_full_unstemmed |
Research advances in renal replacement therapy for hepatorenal syndrome |
title_sort |
research advances in renal replacement therapy for hepatorenal syndrome |
publisher |
Editorial Department of Journal of Clinical Hepatology |
series |
Linchuang Gandanbing Zazhi |
issn |
1001-5256 1001-5256 |
publishDate |
2016-03-01 |
description |
Hepatorenal syndrome (HRS) is a serious complication of the end-stage liver disease. The overall treatment outcome of HRS is not satisfactory, with a short survival time and a poor prognosis. Currently, renal replacement therapy is one of the main non-transplantation therapeutic methods, but its clinical effect remains controversial. This review summarizes the research on HRS and advances in the clinical effect of renal replacement therapy for HRS, and points out that renal replacement therapy is not suitable as the conventional therapy for HRS, but it can be applied as the pre-transplantation transitional treatment for patients with a plan for liver transplantation, as well as the short-term treatment for non-transplantation patients who do not respond to vasoconstrictors. |
url |
http://www.lcgdbzz.org/qk_content.asp?id=7280 |
work_keys_str_mv |
AT chenli researchadvancesinrenalreplacementtherapyforhepatorenalsyndrome AT meiyong researchadvancesinrenalreplacementtherapyforhepatorenalsyndrome AT yangyibin researchadvancesinrenalreplacementtherapyforhepatorenalsyndrome |
_version_ |
1725744178971803648 |